Sudarshan Pharma Industries has received approval to acquire 10,000 ordinary shares of Singapore Dollar 1 each of Sudarshan Pharma Industries, a company incorporated in Singapore (100% of the paid-up share capital of Sudarshan Pharma Industries). Upon completion of the acquisition, Sudarshan Pharma Industries, Singapore would become a wholly-owned subsidiary of the company.
The acquisition will help the company to expand its business operations in Singapore and other neighbouring countries. The Board of Directors of the Company has, on November 28, 2024, approved same.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
